Certified by Founder
Lodge
INNOVENTRIC
start up
Israel
- Rehovot
- 30/10/2024
- Series B
- $28,500,000
Innoventric is a Structural Heart medical device company specializing in the development of percutaneous heterotopic cross-caval solutions for Tricuspid Regurgitation and right heart disease.
http://www.innoventric.com
#TTVR #Cardiology #MedTech #InterventionalCardiology #heterotopic #crosscaval #medicaldevices
- Industry Medical Device
- Website https://innoventric.com/
- LinkedIn https://www.linkedin.com/company/innoventric/
Zócalo Health | $15,000,000 | (Apr 24, 2026)
Rilian | $17,500,000 | (Apr 24, 2026)
BAND | $17,000,000 | (Apr 24, 2026)
Brev.io | $3,300,000 | (Apr 24, 2026)
Maxed | $850,000 | (Apr 24, 2026)
Omni | $120,000,000 | (Apr 24, 2026)
VREY | $3,859,432 | (Apr 24, 2026)
Astor (YC S25) | $5,000,000 | (Apr 24, 2026)
QMatter | $1,200,000 | (Apr 24, 2026)
Almanac Health | $10,000,000 | (Apr 24, 2026)
Petual | $20,000,000 | (Apr 24, 2026)
C-Infinity | $16,000,000 | (Apr 23, 2026)